Skip to main content

Table 2 FDR q-values for the top 15 pathways across different results from GSEA

From: Modification effect of fenofibrate therapy, a longitudinal epigenomic-wide methylation study of triglycerides levels in the GOLDN study

Pathway name

Pretreatment

FDR q value

Posttreatment

FDR q value

Modification

FDR q value

KEGG_ENDOMETRIAL_CANCER

0.146

0.023

0.040

KEGG_PATHWAYS_IN_CANCER

0.166

0.059

0.137

KEGG_DORSO_VENTRAL_AXIS_FORMATION

0.182

0.067

0.122

KEGG_ADHERENS_JUNCTION

0.141

0.079

0.139

KEGG_TYPE_II_DIABETES_MELLITUS

0.198

0.079

0.092

KEGG_COLORECTAL_CANCER

0.205

0.078

0.107

KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY

0.160

0.081

0.138

KEGG_FOCAL_ADHESION

0.165

0.061

0.153

KEGG_MELANOGENESIS

0.178

0.077

0.139

KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION

0.193

0.017

0.156

KEGG_CHRONIC_MYELOID_LEUKEMIA

0.160

0.134

0.133

KEGG_BASAL_CELL_CARCINOMA

0.153

0.055

0.199

KEGG_CALCIUM_SIGNALING_PATHWAY

0.236

0.067

0.133

KEGG_WNT_SIGNALING_PATHWAY

0.230

0.075

0.133

KEGG_NON_SMALL_CELL_LUNG_CANCER

0.289

0.070

0.109